T3	Citation 235 236	7
T1	Context 123 238	These tumors have a prevalence of approximately 7-14% and a have a poor prognosis compared to luminal A tumors [7].
T2	ACCURATE 32052 32413	In terms of prognosis, Kaplan-Meier survival analysis revealed that claudin-low tumors have a worse prognosis compared to luminal A tumors in both the UNC337 (hazard ratio [HR] of 2.83 and 5.66 for relapse-free survival [RFS] and overall survival [OS], respectively; P < 0.05) and NKI295 data sets (HR of 4.71 and 17.98 for RFS and OS, respectively; P < 0.001).
T4	ACCURATE 31669 31829	Across all three databases, claudin-low tumors showed a prevalence of 7 to 14%, and were mostly ER-/PR-/HER2- (also known as triple-negative tumors, 61 to 71%).
